Provided by Tiger Trade Technology Pte. Ltd.

Agree

68.16
-0.3400-0.50%
Post-market: 68.270.1100+0.16%17:29 EDT
Volume:1.67M
Turnover:114.12M
Market Cap:8.48B
PE:36.81
High:69.82
Open:69.82
Low:67.94
Close:68.50
52wk High:82.08
52wk Low:67.93
Shares:124.38M
Float Shares:122.18M
Volume Ratio:1.19
T/O Rate:1.37%
Dividend:3.14
Dividend Rate:4.61%
EPS(TTM):1.85
EPS(LYR):1.77
ROE:3.70%
ROA:2.40%
PB:1.34
PE(LYR):38.51

Loading ...

Agree Realty Q2 Core Ffo USD 136 Million

THOMSON REUTERS
·
Jul 31

Phase 2 of Kelun Kee Bio's TROP2 ADC Bei Tai La receives NMPA approval for new indications

Stock News
·
Jul 30

Euro Might not Benefit if U.S.-Iran Agree Lasting Peace Deal

Dow Jones
·
Jul 29

VERAXA Biotech Strengthens Patent Portfolio to Protect Core Technology Platforms and Product Candidates

GlobeNewswire
·
Jul 29

Agree Realty Corp Expected to Post Earnings of 47 Cents a Share - Earnings Preview

Reuters
·
Jul 29

BiomX And Water.IO Agree To Updated Zorronet Acquisition Terms

GlobeNewswire
·
Jul 28

Corbus Pharmaceuticals Announces FDA Clearance to Initiate TEMPO-1 Registrational Study of CRB-701 in Patients with 2L Oropharyngeal Cancer

GlobeNewswire
·
Jul 28

Lepu Biopharma’s Claudin 18.2 ADC CMG901 Delivers Positive Global Phase III Gastric Cancer Data

TIPRANKS
·
Jul 28

South Korea, Brazil Agree to Accelerate Mercosur Trade Deal Talks

MT Newswires Live
·
Jul 28

VERAXA Biotech (NASDAQ: VRXA) Advances Bispecific ADC Program Under OmniAb Collaboration

TIPRANKS
·
Jul 28

Adlai Nortye Initiated With Buy on Differentiated RAS-Targeting Pipeline, ADC Strategy and Solid Cash Runway

TIPRANKS
·
Jul 27

Kelun Pharmaceutical's Subsidiary Kelun-Biotech Gets Approval for Clinical Trial of Novel Dual-Load ADC Drug SKB565

Stock News
·
Jul 27

Impact Therapeutics Nominates Preclinical Candidate for GI Cancers

MT Newswires Live
·
Jul 27

IMPACT Therapeutics Unveils First Dual-Payload ADC Preclinical Candidate IMP3201

TIPRANKS
·
Jul 27

Does Agree Realty's Higher 2026 Dividend Payout Reveal a Deeper Capital Allocation Shift for ADC?

Simply Wall St.
·
Jul 26

BIOKIN's T-Bren (HER2 ADC) Trial Enrolls First Subject in Phase III Study

Stock News
·
Jul 26

West Java's Street Crime Bounty Plan: Does the Minister Agree?

Tempo
·
Jul 24

Press Release: Samsung Epis Holdings Reports Second Quarter and Half-year 2026 Financial Results

Dow Jones
·
Jul 24

Sichuan Biokin Pharmaceutical's ADC Enters Phase Three Trial for Biliary Tract Cancer

MT Newswires Live
·
Jul 24

Earning Preview: Agree Realty revenue is expected to increase by 18.08%, and institutional views are bullish

Earnings Agent
·
Jul 24